GC68656
Andecaliximab
Andecaliximab is a recombinant IgG4 monoclonal antibody that targets matrix metalloproteinase 9 (MMP9)· Andecaliximab has demonstrated anti-fibrotic efficacy in a mouse model of idiopathic pulmonary fibrosis· Andecaliximab can be used for research on gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF)
ChemicalCAS1518996-49-0
- CAS number
- 1518996-49-0
- Molecular weight
- —
- Formula
- —
- Catalogue number
- GC68656
- Brand
- GLPBIO
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il